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Antibiotic use in infants hospitalised with HIV-related pneumonia
in Harare, Zimbabwe
ICHITSIKE
Abstract
Objective: To describe the clinical features of infants admitted with HIV-related pneumonia and to describe 
antibiotic use in relation to recommended treatment guidelines.
Design: Case series.
Setting: Paediatric medical wards of two' University Teaching Hospitals, Parirenyatwa and Harare Central 
Hospitals.
Subjects: 100 infants aged one to 12 months admitted with HIV-related pneumonia 
Main Outcome Measures: Mortality and antibiotic use in the two hospitals.
Methods: Records of 100 infants admitted for 48 hours or more with features of HIV-related pneumonia were 
analysed for clinical features and antibiotic use.
Results: 77% of patients were in the first six months of life with a peak age of two months and a median of 
four months (Qj = 2, Q3 = 6). The median age of children admitted to Parirenyatwa hospital was 5.5 months 
(Q1 = 3, Q3 =7) and in Harare hospital it was three months (Q, = 2, Q3 = 6). The difference was statistically 
significant, p=0.035.
Fifty four percent of cases received penicillin, aminoglycoside and cotrimoxazole and overall only 30% of 
prescriptions complied with Essential Drug List of Zimbabwe (EDLIZ) recommendations for treatment of 
severe pneumonia in children with HIV infection.
The overall mortality was 27.0%. The mortality in Harare Central Hospital was 40.4% and 15.7% in 
Parirenyatwa. The difference was statistically significant p= 0.005.
Conclusion: The difficulties in establishing the cause of the pneumonia in infants with HIV infection was a 
contributory factor to lack of adherence to standard treatment guidelines. In countries with a high prevalence 
of HIV infection and with limited resources, a clinical case definition for Pneumocystis carinii pneumonia 
(PCP) is required as a measure to provide treatment for infants with HIV related pneumonia which is evidence 
based. This approach will also promote rational antibiotic prescribing and will contain cost.
CentAfr J Med 2001;47(6):150-5
Introduction
AIDS is now the biggest single cause of child death in 
Zimbabwe reversing yea'rs of steady progress in child 
survival.1 In Harare the infant mortality rate doubled from 
30 to 60 per 1000 between 1990 and. 1996 and in the under 
five year olds the mortality rate almost trebled from eight 
to 20 per 1 000 in the same period.2 Such high infection 
rates will have far reaching effects on the health sector 
putting additional strain on an already overburdened health 
care system in the country.
HIV Diagnosis in Children.
The diagnosis of HIV/AIDS infection in children is 
based on clinical signs and laboratory investigations.
Clinical signs commonly found useful for diagnosis of 
HIV infection are recurrent infections; oral thrush; persistent 
fever; persistent diarrhoea; generalised lymphadenopathy; 
developmental delay; weight loss or failure to thrive; 
severe or repeated pneumonia;severe pruritic dermatitis; 
chronic parotitis; persistent hepatosplenom egaly; 
opportunistic infections; neoplasms and neurological 
involvement.3
The laboratory diagnosis of HIV infection in children is 
made by either antibody testing, viral antigen testing, viral 
nucleic acid testing or viral culture.
The Centre for Disease Control (CDC) definition for 
diagnosing HIV infection for children under 18 months of 
age is based on viral detection assays or on clinical criteria
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that include opportunistic infections.4 In developing 
countries the antibody measurement is the most widely 
used technique but is of limited value in the first 15 tol8 
months of life due to passive transfer of maternal antibodies.. 
The CDC definition is not applicable either because of lack 
of resources for either viral detection assays or for making 
clinical diagnosis of opportunistic infections. T o overcome 
these limitations and provide a standardised basis for 
diagnosing HIV infection in children in developing 
countries the WHO produced a definition5 based on a set of 
clinical signs categorised into major and minor. In order to 
improve the sensitivity and positive predictive value the 
case definition was later modified to include persistent or 
severe lower respiratory tract infection as a major sign.
Lepage et a l6 have further simplified the case definition 
to acute lower respiratory infection and generalised 
lymphadenopathy. This simple definition was found to 
have better sensitivity, specificity and positive predictive 
value compared to the WHO clinical case definition for 
paediatric AIDS.
In documenting features of children with symptomatic 
HIV infection in. this centre, Nkrumah et al.1 reported 
generalised lymphadenopathy to be the commonest 
presentation. Other common features^vere hepatomegaly, 
splenomegaly and oral candidiasis.
In this study the criteria for diagnosing HIV infection in 
infants was the presence of generalised lymphadenopathy 
with hepatosplenomegaly, oral candidiasis and a strongly 
positive HIV antibodies by enzyme-linked immunosorbent 
assay.
HIV Related Respiratory Infections.
A significant cause of hospital admissions and deaths in 
patients with HIV infection in Africa are respiratory 
infections. Common bacterial infections are Streptococcus 
pneumoniae, Haemophilus influenzae, Staphylococcus 
aureus and M. tuberculosis. 8'g These are the same pathogens 
that commonly cause pneumonia in the immunocompetent 
patients. Pneumocystis carinii which is a common pathogen 
causing pneumonia in HIV infected patients in industralised 
countries1011 has been reported less commonly in 
Africa.12' 14
The reason for this variability is uncertain but could be 
due to several factors from under-reporting to under­
diagnosis or geographic variability.15 
National Treatment Guidelines.
The mainstay of management of children with respiratory 
infections are antimicrobials. In an effort to provide a 
rational approach to the management of respiratory 
infections the Ministry of Health of Zimbabwe has 
developed treatment guidelines as in the EDLIZ.16
The recommended first line treatment in infants with 
severe HIV related pneumonia in the EDLIZ is 
benzylpenicillin plus gentamycin otr kanamycin.lf,Such a 
recommendation is empirical and based on the spectrum of 
common pathogens causing pneumonia in patients with 
HIV infection in developing countries.
Study Objectives. S
The objectives of this study were : 9
1. To describe the characteristics of infants with HIV9
related pneumonia admitted into two main teaching* 
hospitals. ■
2. To describe the antibiotic prescribing pattern of health I
workers for severe HIV related pneumonia in the two ■  
hospitals. ■
3. To assess compliance of health care workers with I
national treatment guidelines for severe pneumonia I  
in children with HIV infection. 1
Materials and Methods
The study was conducted in the paediatric medical wards 
of the two main referral hospitals, Harare Central hospital 
and Parirenyatwa Hospital which are in the capital city. 
These are University Teaching Hospitals and get referrals 
from municipal clinics and health centres from the 
provinces.
The study population were children one month and 
above admitted for over 48 hours during the two months 
May and June 1997, with the following characteristics: j
1. Admitting diagnosis of severe pneumonia using the > 
WHO definition.17
2. Have clinical features of HIV infection in the presence 
of repeated strongly positive serology by enzyme- 
linked im m unosorbent assay test by Abbot 
Laboratories.
Sampling.
The one hundred records of patients with the above 
eligibility criteria were collected by simple random method 
from the discharge registers of the two hospitals, Harare 
(n=49) and Parirenyatwa hospital (n=51). During the same 
period there were 776 patients aged zero to eight years 
admitted to Harare Hospital and a total of 326 patients aged 
zero tol2 years admitted to Parirenyatwa Hospital.
Data.
In order to describe the patients’ characteristics, the 
following variables were retrieved from patients’ records: 
age; sex; hospital; nutritional status; duration of hospital 
stay,; mortality and antibiotics prescribed. The data was 
obtained using a precoded data collection form and entered 
by a trained research assistant. In addition all records were 
reviewed by the Principal Investigator.
The standard treatment guidelines in the national policy 
document EDLIZ were used to assess prescribing 
adherence.
Analysis of Data.
The analysis was performed by using Epi Info 6 (CDC 
Atlanta, Georgia) and Stata statistical packages. 
Characteristics of patients and treatment variables were 
compared between the two hospitals and were also 
compared between patients who died and those who 
survived.
To compare means the student’s t-test was used or its 
non-parametric equivalent (Kruskal-Wallis) if data were
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skewed. For categorical data the Chi squared test was used 
to compare differences inproportions between two groups. 
Stepwise logistic regression models were used to determine 
factors independently associated with mortality. Wald 
tests were used to determine statistical significance of 
variables.
Tests of significance at p< 0.05 were used to determine 
statistical significance.
Results
Age Distribution.
Over a period of eight weeks in, May and June 1997 the 
hospital records of 100 patients aged one tol2 months 
admitted to the two teaching hospitals Harare and 
Parirenyatwa were analysed. The male: female ratio was
0.94.
There were 49 patients at Harare Hospital and 51 at 
Parirenyatwa Hospital. Figure I shows the distribution of 
the age in months, of infants admitted. Seventy seven 
percent of the patients admitted were in the first six months 
of life. The peak age was two months and the median was 
four months (Q1 = 2, Q3= 6). The median age of children 
admitted to Parirenyatwa hospital was 5.5 months (Q, = 3, 
Q3 = 7) and in Harare Hospital it was 3.0 months (Q1 = 2, 
Q3 =6). The difference was statistically significant, p = 
0.035.
Duration of Hospital Stay.
The median duration of (tospital stay was six days (Qt -  4, 
Q3 =10). The median duration of hospital stay for 
Parirenyatwa hospital was seven days (Q1 = 5 Q3 = 11) and 
that for Harare hospital was six days (Qj = 4, Q3 = 8). The 
difference was not statistically significant, p=0.075. 
Nutritional Status.
The nutritional status of the patients was assessed using 
the Wellcome Classification18 (Table I).
Table I: Nutritional status (n=94). -
Nutritional Status Frequency %
Well nourished 50 53.2
Underweight 36 38.3
Marasmic 8 8.5
Nutritional status was recorded in 94 patients. Only 
53.2% of the patients were well nourished, 38.3% were 
underweight, 8.5% marasmic and none had kwashiorkor. 
When stratified by age groups as shown in Table II, 
children below six months had a significantly better 
nutritional status compared to children over six months
p <  0.001.
Overall there was no difference in the nutritional status 
between patients admitted to Parirenyatwa or Harare 
Hospital, p= 0.514.
Table II: Nutritional status according to age group (n=94).
Age Group Good <80% standard <60% standard Total
0-6 months 45 (63.4%) 23 (32.4%) 3 (4.2%) 71
7-12 months 5 (21.7%) 13 (56.2%) 5(21.7%) 23
Total 50 36 '8 94
Drug Use.
The patients admitted received a total of293 prescriptions 
of various combinations with an average of 2.9 drugs per 
patient during the hospital stay. The least number of drugs 
received was one and the maximum was six per patient. 
Drugs were changed or added because of lack of clinical 
improvement in the patients. None of the patients had 
microbiological evidence as a basis for either initiating the 
drug treatment or change of treatment. The number of 
drugs per patient is shown in Figure I I .
Figure II: Number of antibiotics prescribed per patient 
(n=293).
Antibacterial Use.
The various antibacterial drugs used and the frequency 
are shown in Table III.
The 293 prescriptions constituted 12 different kinds of 
antibacterial drugs. All drugs were given parenterally 
except cotrimoxazole, Erythromycin and the anti­
tuberculous medication.
The four commonest drugs used, were gentamycin , 
benzylpenicillin, cotrimoxazole and ampicillin. Ampicillin 
was used when benzylpenicillin was not available. These 
four drugs which formed 81.2% of all antibacterials 
prescribed were used in the following combinations of
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r--...,. Table III; Frequency o f antibacterial use.
R^fiBiStgrja^Agent Percent of Patients 
(n=100)
% of all Drugs Used 
(n=293)
Gentamycin 86.0 29.4
Benzylpenicillin 53.0 18.7
Cotrimoxazole 54.0 18.4
Ampicillin 43.0 14.6
.Cloxacillin 14.0 4.7
Chloramphenicol 12.0 4.1
Ceftriaxone 11.0 3.8
Isoniazid 4.0 1.4
Rifampicin 4.0 1.4
Pyrazinamide 3.0 . 1.0
Kanamycin 3.0 1.0
Erythromycin 2.0 0.7
gentamycin and benzylpenicillin with or without 
cotrimoxazole or gentamycin and ampicillin with orwithout 
cotrimoxazole.
Comparison of Antibacterial use at Parirenyatwa and 
Harare Hospital.
Of the total of 293 prescriptions, 125 (42.7%) were used 
at Harare and 168 (57.3%) were used at Parirenyatwa. The 
average number of drugs used at Harare was 2.5 and at 
Parirenyatwa it was 3.3. Table IV shows the drugs used at 
the two hospitals.
Table IV: Use o f commonly prescribed drugs in both 
hospitals.
Drugs Harare Hosp. Pari. Hosp. X2 df p value
Benzylpen . 12% 92% 64.06 1 <0.001
Cotrimoxazole 43% 65% 5.34 1 0.02
Ampicillin 84% 4% 63.02 1 <0.01
Gentamycin 90% 82% 0.73 1 0.393
Cloxacillin - 8% 27% 6.55 1 0.011
Benzyl penicillin, cotrimoxazole and cloxacillin were 
used more frequently at Parirenyatwa compared to Harare 
Hospital p< 0.001, 0.021 and 0.011 respectively, whereas 
ampicillin was used more frequently at Harare Hospital, 
p = 0.001. There was no statistically significant difference in 
the use of gentamycin between the two hospitals, p= 0.393. 
Anti-tuberculous Drugs.
Fourpatients had anti-tuberculous drugs. All four patients 
had other antibiotics in addition. Two had benzylpenicillin, 
gentamycin and cotrimoxazole. A third patient had 
benzylpenicillin and gentamycin and the fourth had 
benzylpenicillin and cotrimoxazole.
Mortality.
Of the 100 patients studied 27 died giving an overall 
mortality rate of 27.0%.
The mortality rate in Harare hospital was 40.4% which 
was significantly more than the mortality rate at 
Parirenyatwa which was 15.7%, OR: 3.69 (95%'CI= 1.42 
to 9.61; p= 0.005). There was n& statistically significant 
difference in age, sex, duration in hospital stay and 
nutritional status between those who died and those who 
survived.
Risk Factors for Mortality.
Step-wise logistic regression analysis was carried out to 
determine significant factors associated with mortality as 
shown in Table V.
Table V: Risk factors for mortality using logistic 
regression analysis. >
Factor Odds Ratio (95% Cl) WaldTest p value
Benzylpen . 0.32 (0.12-0.82) -2.4 0.017
Ampicillin 3.04 (1.2-7.7) 2.3 0.019
Hospital 3.7 (1.4-9.6) 2.7 0.007
Children admitted to Harare Hospital were 3.69 times 
more likely to die compared to children admitted to 
Parirenyatwa hospital. Mortality was 3.04 times higher in 
children who had ampicillin than in those who did not have 
it. Patients on benzyl penicillin were 68% less likely to die 
than those who were not on it.
t
Discussion
Severe lower respiratory tract infection is a major cause of 
morbidity and mortality in children with HIV infection.10 
Common pathogens causing infection include bacteria and 
Pneumocystis carinii.910 In developing countries poor 
resources and lack of facilities to isolate the pathogens, 
make accurate clinical diagnosis and antibiotic management 
relatively difficult. Studies have shown lack of accurate 
diagnosis as a contributory factor to inappropriate 
prescribing.19-20 Even in situations where resources are 
available difficulties in obtaining diagnostic specimens by 
non invasive means in children are a major factor for lack 
of laboratory confirmation.21
It is therefore imperative that criteria that do not 
necessarily rely on bacteriological confirmation be explored 
to arrive at a logical causation of pneumonia in children 
with HIV infection.
Age of presentation of pneumonia has been found to be 
more useful as an indicator of the etiology of pneumonia 
compared to clinical features or even laboratory tests.22 
Rogers23 in a study on clinical features of HIV related 
pneumonia in children in the USA found PCP to occur in 
72% of children presenting younger than one year compared 
to older children where the incidence of PCP was only 
38%.
Graham et a/24 from Malawi in comparing cases of PCP 
to bacterial pneumonia in children with HIV infection, 
reported an earlier age of presentation in children with 
PCP. In this study the peak age of children admitted was 
two months. Although it is not possible to make any 
inference regarding etiology, PCP should still be considered 
as a possibility in a two months old infant presenting with 
HIV related pneumonia.
The view that PCP is rare in Africans12-14 peeds reviewing 
in the light of emerging studies indicating that it is a 
significant cause of pneumonia in children with. HIV
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infection in developing countries. In Malawi PCP is 
responsible for one third of pneumonia mortality in 
children.24 In Zimbabwe, necropsy findings in children 
with HIV infection showed an incidence of PCP to be 
16%.26
In children with HIV infection, the diagnosis of PCP is 
based on clinical presentation including age at risk of 
p ep  26 Treatment with TMP/SMX (Cotrimoxazole) is 
instituted presumptively without waiting for diagnostic 
confirmation.26
In Zimbabwe, where diagnostic facilities are not readily 
available, the recommended treatment for infants with 
HIV infection presenting with severe pneumonia is a 
combination of two antibiotics, parenteral penicillin and 
aminoglycoside.16 This regimen is directed at treating 
common bacterial infections.
In this study 54.0% of cases received penicillin, 
aminoglycoside and cotrimoxazole .
More patients in Parirenyatwa Hospital, 64.7% received 
cotrimoxazole compared to Harare Hospital 42.8.0%.
Overall only 30.0% of prescriptions followed EDLIZ 
recommendations where two drugs, penicillin and 
aminoglycoside were given for treatment of severe 
pneumonia in children with HIV infection.
A main factor for deviation from standard treatment 
guidelines was the addition of cotrimoxazole to penicillin 
and aminoglycoside which are the two recommended 
antibiotics in EDLIZ for the treatment of severe pneumonia. 
This regimen of combining treatment for bacterial 
pneumonia with treatment for PCP in infants presenting 
with HIV related pneumonia reflects the difficulties faced 
by medical practitioners in distinguishing the accurate 
cause of the pneumonia in these infants. This difficulty in 
distinguishing if the pneumonia is due to bacterial 
pneumonia or PCP has implications on the long term 
management of these infants in terms of criteria on which 
to base decisions for PCP prophylaxis. Combining treatment 
for both conditions also has cost implications.
Mortality.
It is not possible from the findings of this study to explain 
the reasons for the higher mortality in Harare Hospital 
compared to Parirenyatwa Hospital. The two factors which 
were significantly different in the two hospitals were the 
age of admission and prescribing pattern. In Harare Hospital 
the median age of admission was three months compared 
to 5.5 months at Parirenyatwa Hospital. Although young 
age is a risk factor for mortality in infants with pneumonia27 
in this study age was not significantly associated with 
mortality.
Benzylpenicillin, cotrimoxazole and cloxacillin were 
prescribed more frequently at Parirenyatwa compared to 
Harare. The only drug that was significantly associated 
with mortality was ampicillin. Ampicillin was prescribed 
more at Harare Hospital where benzylpenicillin was not 
readily available at the time of the study. It is not possible 
to base the difference in mortality between the two hospitals 
on the use of ampicillin. There were several factors that 
could have contributed to the difference in mortality that
tion,
\
r  0 M ''rc- " _
were not addressed, such as.st-ag'eafdisease {5re^  
workload and overcrowding.
This study highlights two W in  fin,dingo^^,. _ __
of presentation of infants wi t h^I^jteMte'd pn&uflloma and 
the lack of adherence to standard-treatment guidelines in 
the management of these infants.
The difficulties in establishing the cause of the pneumonia 
in infants with HIV infection was a contributory factor to 
lack of adherence to standard treatment guidelines. In 
countries with a high prevalence of HIV infection and with 
limited resources, a clinical case definition for PCP is 
required as a measure to provide treatment for infants with 
HIV related pneumonia, which is evidence based. This 
approach will also promote rational antibiotic prescribing 
and will contain cost.
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Anti-Salmonella activity of medicinal plants from Cameroon
T NKUO-AKENJI, R NDIP, A MCTHOMAS, E CHI FRU
Abstract
Objectives: To evaluate the effects of herbal extracts derived from plants commonly prescribed by traditional 
practitioners for the treatment of typhoid fever.
Design: A cross sectional study.
Setting: Departments of Life Sciences and Chemistry, University of Buea, Cameroon. 1 
Subjects: Methanol extracts of plant parts commonly used in Cameroon for the treatment of typhoid fever. 
Main Outcome Measures: Antimicrobial activity was tested using the minimum inhibitory concentration 
(MIC) and the minimum bactericidal concentration (MBC) assays.
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